Skip to content

Educational Materials
- NSCLC Brochure
- Part 1
- Part 2
- Part 3
- Part 4
HCP-Article
- Hcp-2023
- Hcp-2022
- Hcp-2021
- Hcp-2019
- Hcp-2018
- Hcp-2017
- Hcp-2012
- Hcp-2011
HCP-Webcasts
HCP-Gallery
HCP-Events

Back To Lungcancer Main Page

Educational Material, Part 3

Management of Stage III NSCLC Role of Concurrent Chemoradiotherapy & Immunotherapy

01
Mar

This entry was posted in Educational Material, Part 3. Bookmark the permalink.

lungadmin

Role of Radiotherapy and Targeted Therapy for Stage I and II NSCLC

Management of Stage III NSCLC Role of Surgery

HCP Article

HCP Gallery

HCP Events

HCP Webcasts

Articles

Summary of Malaysian National Cancer

Computed Tomography Surveillance of Lung Cancer Survivors

Durvalumab Enters the fray in fight against lung cancer

Malaysia Study on Cancer Survival

WCLC Press Program Press Release De Koning

Get In Touch

Email:
LCNM.secretariat@hotmail.com

Address: No.109, Lot P05A,
Empire Shopping Gallery,
Jln SS16/1, 47500 Subang Jaya,
Selangor, Malaysia

Copyright 2024 © Lung Cancer Network Malaysia

Web Design by JustSimple.

Web Design by JustSimple.

Educational Materials
- NSCLC Brochure
- Part 1
- Part 2
- Part 3
- Part 4
HCP-Article
- Hcp-2023
- Hcp-2022
- Hcp-2021
- Hcp-2019
- Hcp-2018
- Hcp-2017
- Hcp-2012
- Hcp-2011
HCP-Webcasts
HCP-Gallery
HCP-Events
Back To Lungcancer Main Page

X